COMMUNIQUÉS West-GlobeNewswire

OSE Immunotherapeutics Presents New Data on OSE-127 at the American Association of Immunologists (AAI) Annual Meeting May 4-8 2018 in Austin, Texas

07/05/2018 - 08:00

OSE-127 significantly decreases inflammation in colon biopsies from patients with inflammatory bowel diseases and enhances regulatory T-lymphocytes, the cells that fight inflammation. In patients with active mucosal [...]

Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally

07/05/2018 - 07:16

Alcon Cares to donate 100 reprocessed Infiniti ® units to clinics helping underserved patients in Asia, Central and South America, and Africa over the next three years Program to increase access to eye care and the [...]

Dentsply Sirona Reports First Quarter 2018 Results

07/05/2018 - 01:30

Reported Q1 revenues of $956.1 million, up 6.2% compared to prior year; constant currency growth 1 of negative 1.1% Q1 2018 GAAP EPS of $0.35 with Q1 2018 non-GAAP adjusted EPS of $0.45 Updated 2018 guidance: non-GAAP [...]

BrainsWay Receives FDA Clearance of Next Generation Stimulator, Enhancing Its Current Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder

06/05/2018 - 19:25

The company will now have the most advanced stimulator on the market, with enhanced features that increase the ease of use for physicians and integrate a patient management system BrainsWay will be demonstrating the new [...]

Cesca Therapeutics Inc. Presents New Data on its Proprietary X-Series™ Cellular Processing Systems

04/05/2018 - 23:00

Two posters presented at the International Society for Cellular Therapy (ISCT) 2018 Annual Meeting RANCHO CORDOVA, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ: [...]

BeiGene to Present at the Deutsche Bank 43rd Annual Health Care Conference

04/05/2018 - 22:15

CAMBRIDGE, Mass., and BEIJING, China, May 04, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]

VIVUS Announces Date of 2018 Annual Meeting

04/05/2018 - 22:05

CAMPBELL, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS ) (the “Company”), a biopharmaceutical company, today announced that the Company will hold its 2018 Annual Meeting of Stockholders (the “2018 [...]

EY Announces OrthoPediatrics as Entrepreneur of The Year® 2018 Award Finalist in the Midwest

04/05/2018 - 22:01

WARSAW, Ind., May 04, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that Ernst & Young (EY) has [...]

Sientra® to Release First Quarter 2018 Financial Results on Wednesday, May 9, 2018

04/05/2018 - 22:01

SANTA BARBARA, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN ), a medical aesthetics company (“Sientra or the “Company”), announced today that the Company will release its first quarter 2018 [...]

Oncolytics Biotech® Announces Voting Results from its Annual General Meeting of Shareholders

04/05/2018 - 22:00

CALGARY, Alberta and SAN DIEGO, May 04, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX: ONC ) (OTCQX:ONCYF), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]

Novo Nordisk A/S - Share repurchase programme

04/05/2018 - 21:42

Bagsværd, Denmark, 4 May 2018 - As part of the up to DKK 14 billion 2018 share repurchase programme, Novo Nordisk A/S has now initiated a new share repurchase programme for an amount of up to DKK 2.7 billion in [...]

Novo Nordisk A/S purchases B shares worth DKK 1,038 million from Novo Holdings A/S under the 2018 share repurchase programme

04/05/2018 - 21:01

Bagsværd, Denmark, 4 May 2018 - Novo Nordisk A/S has today entered into an agreement to purchase 3,415,895 B shares (nominal DKK 0.20) of a value of DKK 1,038 million from Novo Holdings A/S. This transaction is part of [...]

British Columbia Psychological Association opposes the classification of psychological and psychiatric conditions as “minor injuries” in ICBC legislation

04/05/2018 - 19:00

VANCOUVER, British Columbia, May 04, 2018 (GLOBE NEWSWIRE) -- The British Columbia Psychological Association opposes the inclusion of “a psychological or psychiatric condition” in the definition of “minor injury” in [...]

CellaVision AB: Bulletin from AGM held on May 4, 2018

04/05/2018 - 18:27

Press release 4 May 2018 Bulletin from the Annual General Meeting of CellaVision AB (publ) held on May 4, 2018 At CellaVision's Annual General Meeting, held in Lund today, May 4, 2018, The meeting resolved upon the [...]

Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2018

04/05/2018 - 18:01

Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]

Essilor : Nombre total de droits de vote et d'actions composant le capital social au 30 avril 2018

04/05/2018 - 18:01

Nombre total de droits de vote et d'actions composant le capital social au 30 avril 2018 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France ( [...]

Colibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI System

04/05/2018 - 17:09

EuroPCR Exhibit will Highlight Package-to-Patient Design Broomfield, CO, May 04, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC , a privately held emerging medical device company, today announced that the Colibri [...]

ASLAN Pharmaceuticals Prices Initial Public Offering of Its American Depositary Shares

04/05/2018 - 16:59

SINGAPORE, May 04, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals Limited (TPEx:6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the [...]

Obalon Schedules First Quarter 2018 Financial Results Conference Call for May 10, 2018 at 5:00 p.m. Eastern Time

04/05/2018 - 16:01

SAN DIEGO, May 04, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]